Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes

Diabetes

Volumn 48, Issue 3, 1999, Pages 649-651

  Hurlbert, Marc S ^a   Zhou, Wenbo ^a   Wasmeier, Christina ^b   Kaddis, Farida G ^a   Hutton, John C ^b   Freed, Curt R ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c Box C237 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT;

EID: 0033009587     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.649     Document Type: Article

References (16)

1. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP: Exon 1 of the HD Gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506, 1996
2. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP: Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548, 1997
3. Difiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N: Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993, 1997
4. Okada Y, Taniguchi H, Schimada C: High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science 194:620-622, 1976
5. Teitelman G, Joh TH, Reis DJ: Transformation of catecholaminergic precursors into glucagon (A) cells in mouse embryonic pancreas. Proc Natl Acad Sci U S A 78:5225-5229, 1981
6. Gorelick FS, Chang A, Jamieson JD: Calcium-calmodulin-stimulated protein kinase in developing pancreas. Ant J Physiol 253:469-475, 1987
7. Sharp AH, Loev SJ, Schilling G, Shi-Hua L, Xiao-Jiang L, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DK, Ross CA: Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065-1074, 1995
8. Naya FJ, Huang HD, Qiu Y, Mutoh H, De Mayo FJ, Leiter AB, Tsai MJ: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in Beta2/NeuroD-deficient mice. Genes Dev 11:2323-2334, 1997
9. Sussell L, Kalamaras J, Hartigan-O'Conner DJ, Meneses JJ, Pedersen RA, Rubenstein JL, and Gennan MS: Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 125:2213-2221, 1998
10. Farrer LA: Diabetes mellitus in Huntington's disease. Clin Gen 27:62-67, 1985
11. Podolsky S, Leopold NA, Sax DS: Increased frequency of diabetes mellitus in patients with Huntington's Chorea. Lancet i:1356-1358, 1972
12. Podolsky S, Leopold NA: Growth hormone abnormalities in Huntington's Chorea: effect of L-dopa administration. J Clin Endocrinol Metab 39:36-39, 1974
13. Podolsky S, Leopole NA: Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease. Gerontology 23:55-63, 1977
14. Davidson MB, Green S, Menkes JH: Normal glucose, insulin, and growth hormone responses to oral glucose in Huntington's disease. J Lab Clin Med 84:807-813, 1974
15. Finochhiaro G, Baio G, Micossi P, Pozza G, Di Donato S: Glucose metabolism alterations in Friedreich's ataxia. Neurology 38:1292-1296, 1988
16. Bjorntorp P, Schroder G, Orndahl G: Carbohydrate and lipid metabolism in relation to body composition in myotonic dystrophy. Diabetes 22:238-242, 1973